Drug · DIN 02498200
IBUPROFEN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since March 11, 2025.
- Drug Identification Number (DIN)
- 02498200
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ibuprofen M01AE01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IBUPROFEN | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 23, 2020: NOC 23500New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named IBUPROFEN
- DIN 02439689 · Marketed
- DIN 02238004 · Cancelled Post Market
- DIN 02242408 · Cancelled Post Market
- DIN 02247118 · Cancelled Post Market
- DIN 02263777 · Cancelled Pre Market
- DIN 02268760 · Cancelled Pre Market
- DIN 02309459 · Dormant
- DIN 02395169 · Approved
- DIN 02439697 · Dormant
- DIN 02439700 · Approved
- DIN 02498219 · Cancelled Pre Market